TFS Chemicals - Aspire
Pharma Focus America
Sino Biological - Cytokine

Headlands Research Expands Therapeutic Expertise Through Acquisition of Pharmasite Research, a Clinical Trial Site

Friday, March 01, 2024

Headlands Research, a leading multinational network of clinical trial sites, recently announced its acquisition of Pharmasite Research, a well-established clinical trial site specializing in mental illness and central nervous system (CNS) disorder research.

Kyle Burtnett, CEO of Headlands Research, highlighted the significance of this acquisition in light of the prevalence of mental illness, stating, "With one in five U.S. adults experiencing mental illness in 2021, according to the National Alliance on Mental Illness (NAMI), this translates to nearly 60 million individuals. The addition of Pharmasite Research strengthens our commitment to mental health research and solidifies Headlands' leadership in this crucial field."

Situated just outside Baltimore, Maryland, Pharmasite Research brings over two decades of clinical research experience, aligning closely with Headlands Research's core competencies in mental health and CNS disorders. This strategic acquisition not only enhances Headlands' expertise but also expands its geographical reach in the Mid-Atlantic region, furthering the organization's goal of conducting clinical research among a diverse and representative population. With the inclusion of Pharmasite Research, Headlands Research now boasts a network of 18 sites across the United States and Canada.

Surya Korn, President of Pharmasite Research, highlighted the shared commitment to participant care and study conduct between Pharmasite and Headlands Research, stating, "Our merger allows us to combine knowledge, expertise, and resources to amplify the impact of clinical research for the millions affected by mental illness."

The acquisition of Pharmasite Research follows Headlands Research's expansion efforts in 2023, which saw the addition or establishment of five new sites, including Clinical Research Professionals, AMCR Institute, Headlands Research Detroit, Headlands Research Eastern Massachusetts, and Clinvest Research.

To engage with Headlands Research leadership, individuals are encouraged to attend prominent conferences such as the Anxiety and Depression Association of America (ADAA) Conference, the American Psychiatric Association (APA) Annual Meeting, and the American Society of Clinical Psychopharmacology (ASCP) Annual Meeting.

 

Source: prnewswire.com

patheon - Mastering API production at every scaleWorld Vaccine Congress Europe 2024World Orphan Drug Congress 2024Future Labs Live USA 2024patheon - Revolutionizing PharmaHealthcare CNO SummitHealthcare CMO Summit